JP2023110030A5 - - Google Patents
Info
- Publication number
- JP2023110030A5 JP2023110030A5 JP2023091268A JP2023091268A JP2023110030A5 JP 2023110030 A5 JP2023110030 A5 JP 2023110030A5 JP 2023091268 A JP2023091268 A JP 2023091268A JP 2023091268 A JP2023091268 A JP 2023091268A JP 2023110030 A5 JP2023110030 A5 JP 2023110030A5
- Authority
- JP
- Japan
- Prior art keywords
- netarsudil
- salt
- preventive
- therapeutic agent
- sepetaprost
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2017244847 | 2017-12-21 | ||
| JP2017244847 | 2017-12-21 | ||
| JP2018180658 | 2018-09-26 | ||
| JP2018180658 | 2018-09-26 | ||
| PCT/JP2018/046970 WO2019124488A1 (ja) | 2017-12-21 | 2018-12-20 | セペタプロストとＲｈｏキナーゼ阻害剤との組み合わせ医薬 |
| JP2019560556A JPWO2019124488A1 (ja) | 2017-12-21 | 2018-12-20 | セペタプロストとＲｈｏキナーゼ阻害剤との組み合わせ医薬 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019560556A Division JPWO2019124488A1 (ja) | 2017-12-21 | 2018-12-20 | セペタプロストとＲｈｏキナーゼ阻害剤との組み合わせ医薬 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023110030A JP2023110030A (ja) | 2023-08-08 |
| JP2023110030A5 true JP2023110030A5 (https=) | 2025-10-06 |
Family
ID=66993448
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019560556A Pending JPWO2019124488A1 (ja) | 2017-12-21 | 2018-12-20 | セペタプロストとＲｈｏキナーゼ阻害剤との組み合わせ医薬 |
| JP2023091268A Pending JP2023110030A (ja) | 2017-12-21 | 2023-06-02 | セペタプロストとＲｈｏキナーゼ阻害剤との組み合わせ医薬 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019560556A Pending JPWO2019124488A1 (ja) | 2017-12-21 | 2018-12-20 | セペタプロストとＲｈｏキナーゼ阻害剤との組み合わせ医薬 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US11446273B2 (https=) |
| EP (2) | EP4338751B1 (https=) |
| JP (2) | JPWO2019124488A1 (https=) |
| KR (1) | KR102792934B1 (https=) |
| CN (1) | CN111479568A (https=) |
| CA (1) | CA3086457A1 (https=) |
| ES (2) | ES2972934T3 (https=) |
| TW (2) | TWI788484B (https=) |
| WO (1) | WO2019124488A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019124488A1 (ja) | 2017-12-21 | 2019-06-27 | 参天製薬株式会社 | セペタプロストとＲｈｏキナーゼ阻害剤との組み合わせ医薬 |
| CN111217834B (zh) * | 2020-02-21 | 2021-10-26 | 维眸生物科技（上海）有限公司 | Rock激酶抑制剂的硝基氧衍生物 |
| KR20230051199A (ko) * | 2020-08-13 | 2023-04-17 | 산텐 세이야꾸 가부시키가이샤 | 세페타프로스트를 함유하는 의약 제제 |
| TW202404569A (zh) | 2022-04-22 | 2024-02-01 | 日商參天製藥股份有限公司 | 含有賽佩普斯特(Sepetaprost)之眼科用組合物 |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4952581A (en) | 1987-04-03 | 1990-08-28 | The Trustees Of Columbia University In The City Of New York | Use of a prostaglandin in combination with an adrenergic blocking agent for reduction of intraocular pressure |
| DE3871596T3 (de) | 1987-04-03 | 2000-09-07 | Pharmacia & Upjohn Ab, Stockholm | Anwendung eines Prostaglandins in Mischung mit einem adrenergischen Blocker zur Verminderung des Augen-Innendruckes. |
| ATE289815T1 (de) | 1995-12-21 | 2005-03-15 | Alcon Lab Inc | Verwendung von substituierten isochinolinsulfonyl-verbindungen zur herstellung eines medikaments für die behandlung von glaukom und okularer ischämie |
| BR9711154A (pt) | 1996-08-12 | 1999-08-17 | Yoshitomi Pharmaceutical | Agente farmac-utico contendo inibidor cinase rho |
| JP4212149B2 (ja) | 1998-06-11 | 2009-01-21 | 株式会社デ・ウエスタン・セラピテクス研究所 | 医薬 |
| CA2307285C (en) | 1998-08-17 | 2009-03-31 | Senju Pharmaceutical Co., Ltd. | Agent for prophylaxis and treatment of glaucoma |
| US7217722B2 (en) | 2000-02-01 | 2007-05-15 | Kirin Beer Kabushiki Kaisha | Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same |
| JP4342704B2 (ja) | 2000-07-21 | 2009-10-14 | 富士フイルム株式会社 | 液晶分子の配向方法 |
| US20030018079A1 (en) | 2000-11-13 | 2003-01-23 | Richardson Helene | Treatment |
| PE20020958A1 (es) | 2001-03-23 | 2002-11-14 | Bayer Corp | Inhibidores de la rho-quinasa |
| UY27224A1 (es) | 2001-03-23 | 2002-10-31 | Bayer Corp | Inhibidores de la rho-quinasa |
| WO2002100833A1 (en) | 2001-06-12 | 2002-12-19 | Sumitomo Pharmaceuticals Company, Limited | Rho KINASE INHIBITORS |
| JP4017921B2 (ja) | 2002-06-12 | 2007-12-05 | 高砂熱学工業株式会社 | 暖房室内の空気循環装置 |
| JP4128038B2 (ja) | 2002-07-10 | 2008-07-30 | 富士フイルム株式会社 | 電子ペーパー |
| JP4482726B2 (ja) | 2002-08-29 | 2010-06-16 | 参天製薬株式会社 | Ｒｈｏキナーゼ阻害剤とプロスタグランジン類からなる緑内障治療剤 |
| AU2003257588A1 (en) | 2002-08-29 | 2004-03-19 | Santen Pharmaceutical Co., Ltd. | REMEDY FOR GLAUCOMA COMPRISING Rho KINASE INHIBITOR AND PROSTAGLANDINS |
| AU2003280812A1 (en) | 2002-11-18 | 2004-06-15 | Santen Pharmaceutical Co., Ltd. | REMEDY FOR GLAUCOMA COMPRISING Rho KINASE INHIBITOR AND Beta-BLOCKER |
| TWI367098B (en) | 2004-12-23 | 2012-07-01 | Kowa Co | Treating agent for glaucoma |
| EP1792622A1 (en) * | 2005-11-11 | 2007-06-06 | GPC Biotech AG | Anti-proliferative combination therapy comprising a platinum-based chemotherapeutic agent and EGFR inhibitors or pyrimidine analogues |
| EP2127638A1 (en) * | 2008-05-30 | 2009-12-02 | Santen Pharmaceutical Co., Ltd | Method and composition for treating ocular hypertension and glaucoma |
| JP2011530511A (ja) * | 2008-08-05 | 2011-12-22 | メルク・シャープ・エンド・ドーム・コーポレイション | 治療用化合物 |
| JP2010113957A (ja) | 2008-11-06 | 2010-05-20 | Ntt Docomo Inc | コネクタ |
| PT2415763E (pt) | 2009-03-30 | 2016-03-30 | Ube Industries | Composição farmacêutica para tratamento ou prevenção do glaucoma |
| EP3828172A1 (en) | 2009-05-01 | 2021-06-02 | Aerie Pharmaceuticals, Inc. | Dual mechanism inhibitors for the treatment of disease |
| JP2011013651A (ja) | 2009-07-03 | 2011-01-20 | Mitsumasa Maeda | フレキシブルディスプレイのれん |
| RU2540330C2 (ru) | 2009-07-28 | 2015-02-10 | Оно Фармасьютикал Ко., Лтд. | Бициклическое соединение и его применение для медицинских целей |
| JP5835236B2 (ja) | 2011-01-27 | 2015-12-24 | 小野薬品工業株式会社 | 二環式化合物およびその医薬用途 |
| ES2684351T3 (es) * | 2011-02-04 | 2018-10-02 | Kowa Co., Ltd. | Terapia farmacológica para prevenir o tratar glaucoma |
| WO2019124488A1 (ja) | 2017-12-21 | 2019-06-27 | 参天製薬株式会社 | セペタプロストとＲｈｏキナーゼ阻害剤との組み合わせ医薬 |
-
2018
- 2018-12-20 WO PCT/JP2018/046970 patent/WO2019124488A1/ja not_active Ceased
- 2018-12-20 KR KR1020207020813A patent/KR102792934B1/ko active Active
- 2018-12-20 US US16/955,857 patent/US11446273B2/en active Active
- 2018-12-20 TW TW107146097A patent/TWI788484B/zh active
- 2018-12-20 CN CN201880081551.1A patent/CN111479568A/zh active Pending
- 2018-12-20 EP EP24153812.3A patent/EP4338751B1/en active Active
- 2018-12-20 TW TW111150919A patent/TWI833535B/zh active
- 2018-12-20 ES ES18891292T patent/ES2972934T3/es active Active
- 2018-12-20 ES ES24153812T patent/ES3041644T3/es active Active
- 2018-12-20 CA CA3086457A patent/CA3086457A1/en active Pending
- 2018-12-20 JP JP2019560556A patent/JPWO2019124488A1/ja active Pending
- 2018-12-20 EP EP18891292.7A patent/EP3730138B1/en active Active
-
2022
- 2022-08-15 US US17/887,854 patent/US12201602B2/en active Active
-
2023
- 2023-06-02 JP JP2023091268A patent/JP2023110030A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023110030A5 (https=) | ||
| CN108721265B (zh) | 通过给予秋水仙碱衍生物治疗或预防心血管事件 | |
| Schmidl et al. | Pharmacotherapy of glaucoma | |
| JP2007519649A5 (https=) | ||
| WO2020115555A3 (en) | Crf1 receptor antagonist, pharmaceutical formulations and solid forms thereof for the treatment of congenital adrenal hyperplasia | |
| JP2006523216A5 (https=) | ||
| JP2021515758A5 (https=) | ||
| FI3840753T3 (fi) | Migalastaatti käytettäväksi fabryn taudin hoitomenetelmissä potilailla joilla on gla-geenin mutaatio | |
| RU2004135563A (ru) | Лекарственное средство для лечения повышенной активности мочевого пузыря | |
| RU2018136580A (ru) | Цитратная соль (s)-4-((s)-3-фтор-3-(2-(5,6,7,8-тетрагидро-1,8-нафтиридин-2-ил)этил)пирролидин-1-ил)-3-(3-(2-метоксиэтокси)фенил)бутановой кислоты | |
| EP4442321A3 (en) | Methods of treating sjögren's syndrome using a bruton's tyrosine kinase inhibitor | |
| JP2020529995A5 (https=) | ||
| JPWO2020175629A5 (https=) | ||
| ES3041644T3 (en) | Combination of sepetaprost and netarsudil for use in the prophylaxis or treatment of glaucoma or ocular hypertension | |
| SK99899A3 (en) | Quinoxaline in triple combination with protease inhibitors and reverse transcriptase inhibitors as medicines for treating aids | |
| US8518998B2 (en) | Use of sulfonyl-substituted 2-sulfonylaminobenzoic acid N-phenylamides in the treatment of pain | |
| KR100875908B1 (ko) | 약제 및 약제 키트 | |
| JP2013533870A (ja) | 酒さの予防および／または治療におけるスクワラミドの使用 | |
| JP2022532038A5 (https=) | ||
| JP2021512086A5 (https=) | ||
| Rho | Acute angle-closure glaucoma after albuterol nebulizer treatment | |
| CN110290788A (zh) | 氨基甲酸酯化合物用于预防、缓解或治疗双相障碍的用途 | |
| JP2022505184A5 (https=) | ||
| JP2021511352A5 (https=) | ||
| JP2007518768A (ja) | 有機化合物の組み合わせ物 |